June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Feature discovery using ablation studies for deep learning–based geographic atrophy (GA) progression prediction
Author Affiliations & Notes
  • Julia Cluceru
    Genentech Inc, South San Francisco, California, United States
  • Neha Anegondi
    Genentech Inc, South San Francisco, California, United States
  • Qi Yang
    Genentech Inc, South San Francisco, California, United States
  • Verena Steffen
    Genentech Inc, South San Francisco, California, United States
  • Christina Rabe
    Genentech Inc, South San Francisco, California, United States
  • Michel Friesenhahn
    Genentech Inc, South San Francisco, California, United States
  • Daniela Ferrara
    Genentech Inc, South San Francisco, California, United States
  • Simon S Gao
    Genentech Inc, South San Francisco, California, United States
  • Footnotes
    Commercial Relationships   Julia Cluceru Genentech Inc., San Francisco, California, United States, Code E (Employment); Neha Anegondi Genentech Inc., San Francisco, California, United States, Code E (Employment); Qi Yang Genentech Inc., San Francisco, California, United States, Code E (Employment); Verena Steffen Genentech Inc., San Francisco, California, United States, Code E (Employment); Christina Rabe Genentech Inc., San Francisco, California, United States, Code E (Employment); Michel Friesenhahn Genentech Inc., San Francisco, California, United States, Code E (Employment); Daniela Ferrara Genentech Inc., San Francisco, California, United States, Code E (Employment); Simon Gao Genentech Inc., San Francisco, California, United States, Code E (Employment)
  • Footnotes
    Support  • Yes, Genentech, Inc., South San Francisco, CA, provided support for the study and participated in the study design; conducting the study; and data collection, management, and interpretation
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 3859. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Julia Cluceru, Neha Anegondi, Qi Yang, Verena Steffen, Christina Rabe, Michel Friesenhahn, Daniela Ferrara, Simon S Gao; Feature discovery using ablation studies for deep learning–based geographic atrophy (GA) progression prediction. Invest. Ophthalmol. Vis. Sci. 2022;63(7):3859.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Although convolutional neural networks (CNN) can accurately predict GA growth rate using fundus autofluorescence images (FAF), what drives the prediction accuracy remains unknown. Here, we ablate different regions of FAF to study their contribution to GA progression prediction.

Methods : The dataset included baseline (BL) FAF of patients with bilateral GA enrolled in NCT02479386, NCT02247479, and NCT02247531. GA progression, measured by annualized lesion growth rate (mm2/y), was derived as the slope of a linear fit on available measurements of GA lesion area. Data were split into training (n=1041) and holdout (n=255) sets stratified by BL factors. The training set was further split into 5 stratified folds.
GA lesion masks were generated using a segmentation algorithm for each image. Three regions were delineated using the mask: inside the lesion (Lesion), a 500-µm rim around the lesion (Rim), and the remaining region. All possible combinations of these regions were ablated with black pixels to create new datasets. The VGG16 architecture was trained using a random hyperparameter search on each dataset to predict GA progression. The square of the Pearson correlation coefficient (r2) between predicted and observed GA growth rate was averaged across the 5 folds and used for model selection. The same metric was then used to test performance on the holdout set.

Results : Each 5-fold cross-validation experiment yielded 5 independent models. Fig 1 depicts the holdout r2 of each of these models for each dataset.
Compared with the full FAF (r2=0.44), nearly half of the variability in prediction was explained by capturing only shape and size in the Mask Only dataset (r2=0.24). The No Rim dataset (r2=0.39) showed a greater decrease in performance compared with the Lesion and Rim (r2=0.43) or No Lesion (r2=0.42) datasets. Further, the Rim Only dataset (r2=0.37) performed better compared with the Lesion Only (r2=0.33) and No Lesion or Rim (r2=0.27) datasets.

Conclusions : The intensity and texture within the rim of the FAF contains more predictive features for GA growth rate. We interpret that intensity/texture and morphology have additive contributions to the predictive performance of the CNN. Our findings can be further confirmed by quantifying these features using oculomics and observing predictive performance.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

Fig 1. GA progression is shown with representative images of each ablation technique

Fig 1. GA progression is shown with representative images of each ablation technique

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×